Webcast overview
As the global economy reopens, government agencies, employers, universities, sports teams, individuals, and families are asking: What can we do to ensure everyone’s safety? COVID-19 testing is a significant part of the answer – and will remain crucial even after vaccines or therapies eventually become available.
KPMG is working with government agencies and leading laboratories to set up COVID-19 testing capabilities and best practices.
Featured speakers
Kristin C. Pothier
Required fields
Email Me
Global and National Healthcare and Life Sciences Strategy Leader, and Global Deal Advisory Leader, Healthcare and Life Science, KPMG US
Jessica Lin
Required fields
Email Me
Managing Director, Healthcare and Life Sciences Strategy, KPMG US
Natalie Cummins
Required fields
Email Me
Senior Vice President, Marketing & Payer Relations, BioReference Laboratories
